Wockhardt (WOCKPHARMA)

FAST GROWER

FairStock Score: 24/100 — RISKY

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Current Price₹1,441.1
Market Cap₹22,129.81 Cr
P/E Ratio203.65
ROCE3.75%
ROE0.51%
Dividend Yield0%
Profit Growth384.3%
Debt/Equity0.54
Sales Growth6.13%
Free Cash Flow₹-80,200 Cr
Promoter Holding49.09%
52-Week Range₹1,086.7 — ₹2,420
SectorPharmaceuticals & Biotechnology
Book Value₹267.89

Wockhardt trades with a P/E ratio of 203.65, ROCE of 3.75%, ROE of 0.51%, profit growth of 384.3%, debt-to-equity of 0.54. The FairStock Score of 24/100 flags concerns across multiple fundamental dimensions that investors should examine carefully.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer